½ÃÀ庸°í¼­
»óǰÄÚµå
1463041

À̺ñÀÎÈİú ±â±â ½ÃÀå : Á¡À¯À², ½ÃÀå ±Ô¸ð, µ¿Çâ, »ê¾÷ ºÐ¼® º¸°í¼­ : Á¦Ç°º°, ÃÖÁ¾ »ç¿ëÀÚº°, Áö¿ªº°, ºÎ¹®º° ¿¹Ãø(2024-2032³â)

ENT Devices Market Share, Size, Trends, Industry Analysis Report, By Product (Diagnostic ENT Devices, Surgical ENT Devices, Hearing Implants, Hearing Aids, Others); By End User; By Region; Segment Forecast, 2024- 2032

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: Polaris Market Research | ÆäÀÌÁö Á¤º¸: ¿µ¹® 119 Pages | ¹è¼Û¾È³» : 1-2ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    



¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

Polaris Market ResearchÀÇ ÃÖ±Ù Á¶»ç¿¡ µû¸£¸é ¼¼°èÀÇ À̺ñÀÎÈİú ±â±â ½ÃÀå ±Ô¸ð´Â 2032³â±îÁö 407¾ï 8,000¸¸ ´Þ·¯¿¡ À̸¦ Àü¸ÁÀÔ´Ï´Ù. ÀÌ ¼³¹®Á¶»ç º¸°í¼­´Â ÇöÀç ½ÃÀå ¿ªÇÐÀ» ÀÚ¼¼È÷ ÆÄ¾ÇÇϰí ÇâÈÄ ½ÃÀå ¼ºÀå¿¡ ´ëÇÑ ºÐ¼®À» Á¦°øÇÕ´Ï´Ù.

¶óÀÌÇÁ ½ºÅ¸ÀÏÀÇ º¯È­¿Í ȯ°æ ¿äÀÎÀº À̺ñÀÎÈİú ±â±â ½ÃÀåÀ» Å©°Ô °ßÀÎÇÏ¿© »ç¶÷ÀÇ °Ç°­¿¡ ¿µÇâÀ» ¹ÌĨ´Ï´Ù. ¼ÒÀ½ ³ëÃâ Áõ°¡, Àå½Ã°£ ÇìµåÆù »ç¿ë, Èí¿¬Àº û·Â »ó½Ç ¹× È£Èí±â ÁúȯÀ» À¯¹ßÇÏ¿© º¸Ã»±â ¹× È£Èí±â Áö¿ø Àåºñ¿¡ ´ëÇÑ ¼ö¿ä¸¦ ÃËÁøÇϰí ÀÖ½À´Ï´Ù. ´ë±â¿À¿°À̳ª ¾Ë·¹¸£°Õ µîÀÇ È¯°æ¿äÀÎÀº ¾Ë·¹¸£±â¼º ºñ¿°À̳ª ºÎºñ°­¿° µîÀÇ Áõ»óÀ» ¾ÇÈ­½Ã۱â À§ÇØ °ø±âûÁ¤±â³ª ¾Ë·¹¸£±â Ä¡·áÁ¦°¡ ÇÊ¿äÇÕ´Ï´Ù. COVID-19ÀÇ ´ëÀ¯ÇàÀº È£Èí±â°èÀÇ °Ç°­À» Áß½ÃÇØ, ȯ±â ½Ã½ºÅÛÀ̳ª °ø±â ǰÁú °¨½Ã ÀåÄ¡¿¡ ´ëÇÑ ÁÖ¸ñÀ¸·Î ¿¬°áµÇ°í ÀÖ½À´Ï´Ù.

Àúħ½À ¼ö¼ú¿¡ ´ëÇÑ È¯ÀÚÀÇ ¼±È£µµÀÇ ±ÞÁõÀº À̺ñÀÎÈİú ±â±â ½ÃÀåÀÇ ÁÖ¿ä ÃËÁø¿äÀÎÀÔ´Ï´Ù. ÀÌ·¯ÇÑ ±â¼úÀº ¼ö¼ú ÈÄ ÅëÁõ °æ°¨, ÀÔ¿ø ±â°£ ´ÜÃà, ȸº¹ ½Ã°£ ´ÜÃà µîÀÇ ÀÌÁ¡ÀÌ ÀÖÀ¸¸ç, ºÒÄè°¨°ú È¥¶õÀ» °æ°¨ÇÏ°í ½Í´Ù´Â È¯ÀÚÀÇ ¿ä±¸¿¡ ºÎÇÕÇϰí ÀÖ½À´Ï´Ù. ƯÈ÷ °íÇØ»óµµ ³»½Ã°æ ÀåºñÀÇ ±â¼ú ¹ßÀüÀº ÃÖ¼ÒÇÑÀÇ Á¶Á÷ ÀÛ¾÷À¸·Î Á¤È®ÇÑ Ã³¸®¸¦ °¡´ÉÇÏ°Ô ÇÕ´Ï´Ù. ºÎºñµ¿¿°, ÀεξÏ, ¼ö¸é ¹«È£Èí ÁõÈıº µîÀÇ Áõ»ó¿¡ ´ëÇØ ÀαⰡ ³ô¾ÆÁö°í ÀÖ´Â Àúħ½À Á¢±Ù¹ýÀº ¹Ì¿ëÀûÀÎ °á°ú¸¦ Çâ»ó½Ãŵ´Ï´Ù. ȯÀÚ°¡ ȸº¹À̳ª ¼ö¼ú ÈÄ ºÒÄè°¨ µîÀ» ¿ì¼±Çϱ⠶§¹®¿¡ Àúħ½ÀÀÇ À̺ñÀÎÈİú ±â±â¿¡ ´ëÇÑ ¼ö¿ä°¡ ³ô¾ÆÁö°í ÀÖ¾î, Á¦Á¶¾÷ü °¢»ç´Â Çõ½ÅÀûÀÎ ¼Ö·ç¼ÇÀ» °³¹ßÇØ, ½ÃÀåÀÇ ¼ºÀå¿¡ ¹ÚÂ÷¸¦ °¡Çϰí ÀÖ´Ù ÇÕ´Ï´Ù.

º¸Ã»±â¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡´Â À̺ñÀÎÈİú ±â±â ½ÃÀå¿¡ Å« ºñÁî´Ï½º ±âȸ¸¦ °¡Á®¿Ô½À´Ï´Ù. ºí·çÅõ½º ¿¬°á ¹× ¼ÒÀ½ °¨¼Ò¿Í °°Àº ±â´ÉÀ» Æ÷ÇÔÇÑ º¸Ã»±â ±â¼úÀÇ ¹ßÀüÀÌ º¸Ã»±âÀÇ ¸Å·ÂÀ» Çâ»ó½Ã۰í ÀÖ½À´Ï´Ù. ¶Ç, Å« ¼Ò¸®¿¡ ³ëÃâµÇ´Â µîÀÇ ¶óÀÌÇÁ ½ºÅ¸ÀÏ ¿äÀεµ, ´Ù¾çÇÑ ¿¬·ÉÃþ¿¡¼­ ¼ö¿ä¸¦ ÃËÁøÇϰí ÀÖ½À´Ï´Ù. °Ô´Ù°¡ ³­Ã»°ú °ü·ÃµÈ ÀǽÄÀÌ ³ô¾ÆÁü¿¡ µû¶ó ½ÃÀåÀÌ ´õ¿í Ȱ¼ºÈ­µÇ°í ÀÖ½À´Ï´Ù.

»õ·Î¿î ½ÃÀåÀÇ ÃâÇöÀº À̺ñÀÎÈİú ±â±â ½ÃÀå¿¡ Å« ±âȸ¸¦ °¡Á®¿Ô½À´Ï´Ù. ½ÅÈï°æÁ¦±¹°ú ÀÇ·á¼­ºñ½º°¡ ¹ÌÄ¡Áö ¸øÇϰí ÀÖ´Â Áö¿ªÀÇ ÇコÄÉ¾î ¹× ÀÎÇÁ¶óÀÇ °³¼±ÀÌ, ±Í, ÄÚ ¹× ¸ñÀÇ ¾î´À Áúȯ¿¡ ´ëÀÀÇÏ´Â ±â±â¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡¸¦ µÞ¹ÞħÇϰí ÀÖ½À´Ï´Ù. Áß·ù°è±ÞÀÇ Àα¸ Áõ°¡¿Í ÇコÄɾî ÁöÃâ Áõ°¡´Â ÀÌ·¯ÇÑ ½ÃÀå¿¡¼­ ¼ö¿ä¸¦ ´õ¿í ³ôÀÔ´Ï´Ù. ÈÞ´ë¿ë Áø´Ü µµ±¸ ¹× ¿ø°Ý ÀÇ·á ¼Ö·ç¼Ç°ú °°Àº ±â¼ú ¹ßÀüÀ¸·Î À̺ñÀÎÈİú ±â±â´Â ´õ Ä£¼÷ÇØÁ³½À´Ï´Ù. Á¤ºÎÀÇ ÀÌ´Ï¼ÅÆ¼ºê¿Í ±¹Á¦ ÆÄÆ®³Ê½ÊÀº °Ç°­ °ü¸® ÀÎÇÁ¶ó Á¤ºñ¸¦ °­È­Çϰí À̺ñÀÎÈİú ¼­ºñ½º¿¡ ´ëÇÑ Á¢±Ù¼ºÀ» Çâ»ó½Ã۰í ÀÖ½À´Ï´Ù.

À̺ñÀÎÈİú ±â±â ½ÃÀå º¸°í¼­ ÇÏÀ̶óÀÌÆ®

2023³â û·Â »ó½Ç, ³ëÈ­, ÀÎÁöµµ ¹× Á¢±Ù¼º Çâ»óÀ¸·Î º¸Ã»±â ºÐ¾ß°¡ Å« ÆÇ¸Å Á¡À¯À²À» Â÷ÁöÇß½À´Ï´Ù.

2023³â¿¡´Â ±¤¹üÀ§ÇÑ Ä¡·á ¿É¼Ç, ÀÔ¿ø, ¿Ü·¡ ¼­ºñ½º ¹× ±ÔÁ¤ Áؼö¸¦ ÅëÇØ º´¿ø ¹× Ŭ¸®´Ð ºÎ¹®ÀÌ Å« ¼öÀÍ Á¡À¯À²À» Â÷ÁöÇß½À´Ï´Ù.

2023³â¿¡´Â ºÏ¹Ì°¡ °í±Þ ÀÇ·á ÀÎÇÁ¶ó, À̺ñÀÎÈİú ÁúȯÀÇ ³ôÀº À¯º´·ü, °í·ÉÈ­ Àα¸ Áõ°¡·Î ¼¼°è ½ÃÀåÀ» µ¶Á¡Çß½À´Ï´Ù.

ÄÚŬ·¹¾î(Cochlear Limited), µ¥¸¸Æ®(Demant A/S), Á¸½¼ ¿£µå Á¸½¼(Johnson & Johnson), Ä® ½´Æ®¸£Ã÷(Karl Storz GmbH &Co.KG, Medtronic, Siemens Healthineers, Smith &Nephew) µîÀÔ´Ï´Ù.

¸ñÂ÷

Á¦1Àå ¼­·Ð

Á¦2Àå ÁÖ¿ä ¿ä¾à

Á¦3Àå Á¶»ç ¹æ¹ý

Á¦4Àå ¼¼°èÀÇ À̺ñÀÎÈİú ±â±â ½ÃÀå ÀλçÀÌÆ®

  • À̺ñÀÎÈİú ±â±â ½ÃÀå-¾÷°è ½º³À¼¦
  • À̺ñÀÎÈİú ±â±â ½ÃÀå ¿ªÇÐ
    • ¼ºÀå ÃËÁø¿äÀΰú ±âȸ
      • À̺ñÀÎÈİú ÁúȯÀÇ ÀÌȯÀ²ÀÌ Áõ°¡ÇÔ¿¡ µû¶ó Á¦Ç° ¼ö¿ä°¡ Áõ°¡ÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.
      • °í·ÉÈ­ Àα¸ Áõ°¡¿¡ ÀÇÇØ À̺ñÀÎÈİú ±â±â ½ÃÀåÀÇ ¼ºÀåÀÌ ÃËÁøµÉ °ÍÀ¸·Î ¿¹»ó
    • ¾ïÁ¦¿äÀÎ ¹× °úÁ¦
      • À̺ñÀÎÈİú ±â±âÀÇ °íºñ¿ëÀº ½ÃÀåÀÇ ¼ºÀåÀ» ¹æÇØÇÒ °¡´É¼ºÀÌ ³ô´Ù
  • PESTLE ºÐ¼®
  • À̺ñÀÎÈİú ±â±â ¾÷°è µ¿Çâ
  • ¹ë·ùüÀÎ ºÐ¼®
  • COVID-19ÀÇ ¿µÇ⠺м®

Á¦5Àå ¼¼°èÀÇ À̺ñÀÎÈİú ±â±â ½ÃÀå : Á¦Ç°º°

  • ÁÖ¿ä Á¶»ç °á°ú
  • ¼­¹®
  • Áø´Ü¿ë À̺ñÀÎÈİú ±â±â
  • ¿Ü°ú¿ë À̺ñÀÎÈİú ±â±â
  • û°¢ ÀÓÇöõÆ®
  • º¸Ã»±â
  • ±âŸ

Á¦6Àå ¼¼°èÀÇ À̺ñÀÎÈİú ±â±â ½ÃÀå : ÃÖÁ¾ »ç¿ëÀÚº°

  • ÁÖ¿ä Á¶»ç °á°ú
  • ¼­¹®
  • º´¿ø ¹× Áø·á¼Ò
  • ȨÄɾî
  • ¿Ü·¡¼¾ÅÍ
  • ±âŸ

Á¦7Àå ¼¼°èÀÇ À̺ñÀÎÈİú ±â±â ½ÃÀå : Áö¿ªº°

  • ÁÖ¿ä Á¶»ç °á°ú
  • ¼­¹®
    • À̺ñÀÎÈİú ±â±â ½ÃÀå Æò°¡ : Áö¿ªº°(2019-2032³â)
  • À̺ñÀÎÈİú ±â±â ½ÃÀå-ºÏ¹Ì
    • ºÏ¹Ì : À̺ñÀÎÈİú ±â±â ½ÃÀå : ÃÖÁ¾ »ç¿ëÀÚº°(2019-2032³â)
    • ºÏ¹Ì : À̺ñÀÎÈİú ±â±â ½ÃÀå : Á¦Ç°º°(2019-2032³â)
    • À̺ñÀÎÈİú ±â±â ½ÃÀå-¹Ì±¹
    • À̺ñÀÎÈİú ±â±â ½ÃÀå-ij³ª´Ù
  • À̺ñÀÎÈİú ±â±â ½ÃÀå-À¯·´
    • À¯·´ : À̺ñÀÎÈİú ±â±â ½ÃÀå : ÃÖÁ¾ »ç¿ëÀÚº°(2019-2032³â)
    • À¯·´ : À̺ñÀÎÈİú ±â±â ½ÃÀå : Á¦Ç°º°(2019-2032³â)
    • À̺ñÀÎÈİú ±â±â ½ÃÀå-¿µ±¹
    • À̺ñÀÎÈİú ±â±â ½ÃÀå-ÇÁ¶û½º
    • À̺ñÀÎÈİú ±â±â ½ÃÀå-µ¶ÀÏ
    • À̺ñÀÎÈİú ±â±â ½ÃÀå-ÀÌÅ»¸®¾Æ
    • À̺ñÀÎÈİú ±â±â ½ÃÀå-½ºÆäÀÎ
    • À̺ñÀÎÈİú ±â±â ½ÃÀå-³×´ú¶õµå
    • À̺ñÀÎÈİú ±â±â ½ÃÀå-·¯½Ã¾Æ
  • À̺ñÀÎÈİú ±â±â ½ÃÀå-¾Æ½Ã¾ÆÅÂÆò¾ç
    • ¾Æ½Ã¾ÆÅÂÆò¾ç : À̺ñÀÎÈİú ±â±â ½ÃÀå : ÃÖÁ¾ »ç¿ëÀÚº°(2019-2032³â)
    • ¾Æ½Ã¾ÆÅÂÆò¾ç : À̺ñÀÎÈİú ±â±â ½ÃÀå : Á¦Ç°º°(2019-2032³â)
    • À̺ñÀÎÈİú ±â±â ½ÃÀå-Áß±¹
    • À̺ñÀÎÈİú ±â±â ½ÃÀå-Àεµ
    • À̺ñÀÎÈİú ±â±â ½ÃÀå-¸»·¹À̽þÆ
    • À̺ñÀÎÈİú ±â±â ½ÃÀå-ÀϺ»
    • À̺ñÀÎÈİú ±â±â ½ÃÀå-Àεµ³×½Ã¾Æ
    • À̺ñÀÎÈİú ±â±â ½ÃÀå-Çѱ¹
  • À̺ñÀÎÈİú ±â±â ½ÃÀå-Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«
    • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä« : À̺ñÀÎÈİú ±â±â ½ÃÀå : ÃÖÁ¾ »ç¿ëÀÚº°(2019-2032³â)
    • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä« : À̺ñÀÎÈİú ±â±â ½ÃÀå : Á¦Ç°º°(2019-2032³â)
    • À̺ñÀÎÈİú ±â±â ½ÃÀå-»ç¿ìµð¾Æ¶óºñ¾Æ
    • À̺ñÀÎÈİú ±â±â ½ÃÀå-UAE
    • À̺ñÀÎÈİú ±â±â ½ÃÀå-À̽º¶ó¿¤
    • À̺ñÀÎÈİú ±â±â ½ÃÀå-³²¾ÆÇÁ¸®Ä«
  • À̺ñÀÎÈİú ±â±â ½ÃÀå-¶óƾ¾Æ¸Þ¸®Ä«
    • ¶óƾ¾Æ¸Þ¸®Ä« : À̺ñÀÎÈİú ±â±â ½ÃÀå : ÃÖÁ¾ »ç¿ëÀÚº°(2019-2032³â)
    • ¶óƾ¾Æ¸Þ¸®Ä« : À̺ñÀÎÈİú ±â±â ½ÃÀå : Á¦Ç°º°(2019-2032³â)
    • À̺ñÀÎÈİú ±â±â ½ÃÀå-¸ß½ÃÄÚ
    • À̺ñÀÎÈİú ±â±â ½ÃÀå-ºê¶óÁú
    • À̺ñÀÎÈİú ±â±â ½ÃÀå-¾Æ¸£ÇîÆ¼³ª

Á¦8Àå °æÀï ±¸µµ

  • È®´ë ¹× Àμö ºÐ¼®
    • È®´ë
    • Àμö
  • ÆÄÆ®³Ê½Ê, Çù¾÷, °è¾à ¹× Àü½Ãȸ

Á¦9Àå ±â¾÷ ÇÁ·ÎÆÄÀÏ

  • Ambu A/S
  • Atos Medical
  • Cochlear Limited
  • Demant A/S
  • GN Store Nord A/S
  • Johnson & Johnson
  • Karl Storz GmbH & Co. KG
  • Medtronic
  • Olympus Corporation
  • Pentax of America, Inc.
  • Rion Co., Ltd.
  • Siemens Healthineers
  • Smith & Nephew
  • Sonova Holding AG
  • Stryker Corporation
AJY 24.04.25

The global ENT Devices market size is expected to reach USD 40.78 billion by 2032, according to a new study by Polaris Market Research. The report "ENT Devices Market Share, Size, Trends, Industry Analysis Report, By Product (Diagnostic ENT Devices, Surgical ENT Devices, Hearing Implants, Hearing Aids, Others); By End User; By Region; Segment Forecast, 2024- 2032" gives a detailed insight into current market dynamics and provides analysis on future market growth.

Lifestyle changes and environmental factors significantly drive the ENT devices market, impacting human health. Increased noise exposure, prolonged headphone use, and smoking contribute to hearing loss and respiratory conditions, fueling demand for hearing aids and respiratory support devices. Environmental factors such as air pollution and allergens worsen conditions such as allergic rhinitis and sinusitis, necessitating air purifiers and allergy medications. The COVID-19 pandemic has emphasized respiratory health, leading to a focus on ventilation systems and air quality monitoring devices.

The surge in patient preference for minimally invasive procedures is a key driver of the ENT devices market. These techniques offer benefits such as reduced postoperative pain, shorter hospital stays, and faster recovery times, aligning with patients' desire for less discomfort and disruption. Technological advancements, particularly in high-definition endoscopic equipment, enable precise procedures with minimal tissue manipulation. Minimally invasive approaches, increasingly popular for conditions like sinusitis, throat cancer, and sleep apnea, offer improved cosmetic outcomes. As patients prioritize factors such as recovery and postoperative discomfort, demand for minimally invasive ENT devices is rising, prompting manufacturers to develop innovative solutions and fueling market growth.

The escalating demand for hearing aids is creating substantial opportunities in the ENT devices market. Advancements in hearing aid technology, including features like Bluetooth connectivity and noise reduction, enhance their appeal. Lifestyle factors such as exposure to loud noises also drive demand across various age groups. Moreover, increasing awareness associated with hearing loss further fuels the market.

The emergence of new markets presents significant opportunities within the ENT devices market. Developing economies and improving healthcare infrastructure in underserved regions drive heightened demand for devices addressing ear, nose, and throat disorders. Rising middle-class populations and increased healthcare spending in these markets fuel the demand further. Technological advancements, including portable diagnostic tools and telemedicine solutions, make ENT devices more accessible. Government initiatives and international partnerships bolster healthcare infrastructure development, enhancing access to ENT services.

ENT Devices Market Report Highlights

In 2023, the hearing aids segment held significant revenue share owing to prevalence of hearing loss, aging population, and rising awareness & accessibility.

In 2023, the hospitals and clinics segment held significant revenue share owing to wide range of treatment options, inpatient and outpatient services, and regulatory compliance.

In 2023, North America region dominated the global market due to advanced healthcare infrastructure, high prevalence of ENT disorders, and rising aging population.

The market is highly competitive owing to the existence of market players with a global presence, including Cochlear Limited, Demant A/S, Johnson & Johnson, Karl Storz GmbH & Co. KG, Medtronic, Siemens Healthineers, and Smith & Nephew among others.

Polaris Market Research has segmented the ENT Devices market report based on product, end user, and region:

ENT Devices, Product Outlook (Revenue - USD Billion, 2019 - 2032)

  • Diagnostic ENT Devices
  • Surgical ENT Devices
  • Hearing Implants
  • Hearing Aids
  • Others

ENT Devices, End User Outlook (Revenue - USD Billion, 2019 - 2032)

  • Hospitals and Clinics
  • Homecare
  • Ambulatory Centers
  • Others

ENT Devices, Regional Outlook (Revenue - USD Billion, 2019 - 2032)

  • North America
  • U.S.
  • Canada
  • Europe
  • France
  • Germany
  • UK
  • Italy
  • Netherlands
  • Spain
  • Russia
  • Asia Pacific
  • Japan
  • China
  • India
  • Malaysia
  • Indonesia
  • South Korea
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Middle East & Africa
  • Saudi Arabia
  • UAE
  • Israel
  • South Africa

Table of Contents

1. Introduction

  • 1.1. Report Description
    • 1.1.1. Objectives of the Study
    • 1.1.2. Market Scope
    • 1.1.3. Assumptions
  • 1.2. Stakeholders

2. Executive Summary

  • 2.1. Market Highlights

3. Research Methodology

  • 3.1. Overview
    • 3.1.1. Data Mining
  • 3.2. Data Sources
    • 3.2.1. Primary Sources
    • 3.2.2. Secondary Sources

4. Global ENT Devices Market Insights

  • 4.1. ENT Devices Market - Industry Snapshot
  • 4.2. ENT Devices Market Dynamics
    • 4.2.1. Drivers and Opportunities
      • 4.2.1.1. Increasing prevalence of ENT disorders is projected to spur the product demand
      • 4.2.1.2. Growing aging population is expected to drive ENT devices market growth
    • 4.2.2. Restraints and Challenges
      • 4.2.2.1. High cost of ENT devices is likely to impede the market growth
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers (Moderate)
    • 4.3.2. Threats of New Entrants: (Low)
    • 4.3.3. Bargaining Power of Buyers (Moderate)
    • 4.3.4. Threat of Substitute (Moderate)
    • 4.3.5. Rivalry among existing firms (High)
  • 4.4. PESTLE Analysis
  • 4.5. ENT Devices Industry trends
  • 4.6. Value Chain Analysis
  • 4.7. COVID-19 Impact Analysis

5. Global ENT Devices Market, by Product

  • 5.1. Key Findings
  • 5.2. Introduction
    • 5.2.1. Global ENT Devices, by Product, 2019-2032 (USD Billion)
  • 5.3. Diagnostic ENT Devices
    • 5.3.1. Global ENT Devices Market, by Diagnostic ENT Devices, by Region, 2019-2032 (USD Billion)
  • 5.4. Surgical ENT Devices
    • 5.4.1. Global ENT Devices Market, by Surgical ENT Devices, by Region, 2019-2032 (USD Billion)
  • 5.5. Hearing Implants
    • 5.5.1. Global ENT Devices Market, by Hearing Implants, by Region, 2019-2032 (USD Billion)
  • 5.6. Hearing Aids
    • 5.6.1. Global ENT Devices Market, by Hearing Aids, by Region, 2019-2032 (USD Billion)
  • 5.7. Others
    • 5.7.1. Global ENT Devices Market, by Others, by Region, 2019-2032 (USD Billion)

6. Global ENT Devices Market, by End User

  • 6.1. Key Findings
  • 6.2. Introduction
    • 6.2.1. Global ENT Devices Market, by End User, 2019-2032 (USD Billion)
  • 6.3. Hospitals and Clinics
    • 6.3.1. Global ENT Devices Market, by Hospitals and Clinics, by Region, 2019-2032 (USD Billion)
  • 6.4. Homecare
    • 6.4.1. Global ENT Devices Market, by Homecare, by Region, 2019-2032 (USD Billion)
  • 6.5. Ambulatory Centers
    • 6.5.1. Global ENT Devices Market, by Ambulatory Centers, by Region, 2019-2032 (USD Billion)
  • 6.6. Others
    • 6.6.1. Global ENT Devices Market, by Others, by Region, 2019-2032 (USD Billion)

7. Global ENT Devices Market, by Geography

  • 7.1. Key findings
  • 7.2. Introduction
    • 7.2.1. ENT Devices Market Assessment, By Geography, 2019-2032 (USD Billion)
  • 7.3. ENT Devices Market - North America
    • 7.3.1. North America: ENT Devices Market, by End User, 2019-2032 (USD Billion)
    • 7.3.2. North America: ENT Devices Market, by Product, 2019-2032 (USD Billion)
    • 7.3.3. ENT Devices Market - U.S.
      • 7.3.3.1. U.S.: ENT Devices Market, by End User, 2019-2032 (USD Billion)
      • 7.3.3.2. U.S.: ENT Devices Market, by Product, 2019-2032 (USD Billion)
    • 7.3.4. ENT Devices Market - Canada
      • 7.3.4.1. Canada: ENT Devices Market, by End User, 2019-2032 (USD Billion)
      • 7.3.4.2. Canada: ENT Devices Market, by Product, 2019-2032 (USD Billion)
  • 7.4. ENT Devices Market - Europe
    • 7.4.1. Europe: ENT Devices Market, by End User, 2019-2032 (USD Billion)
    • 7.4.2. Europe: ENT Devices Market, by Product, 2019-2032 (USD Billion)
    • 7.4.3. ENT Devices Market - UK
      • 7.4.3.1. UK: ENT Devices Market, by End User, 2019-2032 (USD Billion)
      • 7.4.3.2. UK: ENT Devices Market, by Product, 2019-2032 (USD Billion)
    • 7.4.4. ENT Devices Market - France
      • 7.4.4.1. France: ENT Devices Market, by End User, 2019-2032 (USD Billion)
      • 7.4.4.2. France: ENT Devices Market, by Product, 2019-2032 (USD Billion)
    • 7.4.5. ENT Devices Market - Germany
      • 7.4.5.1. Germany: ENT Devices Market, by End User, 2019-2032 (USD Billion)
      • 7.4.5.2. Germany: ENT Devices Market, by Product, 2019-2032 (USD Billion)
    • 7.4.6. ENT Devices Market - Italy
      • 7.4.6.1. Italy: ENT Devices Market, by End User, 2019-2032 (USD Billion)
      • 7.4.6.2. Italy: ENT Devices Market, by Product, 2019-2032 (USD Billion)
    • 7.4.7. ENT Devices Market - Spain
      • 7.4.7.1. Spain: ENT Devices Market, by End User, 2019-2032 (USD Billion)
      • 7.4.7.2. Spain: ENT Devices Market, by Product, 2019-2032 (USD Billion)
    • 7.4.8. ENT Devices Market - Netherlands
      • 7.4.8.1. Netherlands: ENT Devices Market, by End User, 2019-2032 (USD Billion)
      • 7.4.8.2. Netherlands: ENT Devices Market, by Product, 2019-2032 (USD Billion)
    • 7.4.9. ENT Devices Market - Russia
      • 7.4.9.1. Russia: ENT Devices Market, by End User, 2019-2032 (USD Billion)
      • 7.4.9.2. Russia: ENT Devices Market, by Product, 2019-2032 (USD Billion)
  • 7.5. ENT Devices Market - Asia Pacific
    • 7.5.1. Asia Pacific: ENT Devices Market, by End User, 2019-2032 (USD Billion)
    • 7.5.2. Asia Pacific: ENT Devices Market, by Product, 2019-2032 (USD Billion)
    • 7.5.3. ENT Devices Market - China
      • 7.5.3.1. China: ENT Devices Market, by End User, 2019-2032 (USD Billion)
      • 7.5.3.2. China: ENT Devices Market, by Product, 2019-2032 (USD Billion)
    • 7.5.4. ENT Devices Market - India
      • 7.5.4.1. India: ENT Devices Market, by End User, 2019-2032 (USD Billion)
      • 7.5.4.2. India: ENT Devices Market, by Product, 2019-2032 (USD Billion)
    • 7.5.5. ENT Devices Market - Malaysia
      • 7.5.5.1. Malaysia: ENT Devices Market, by End User, 2019-2032 (USD Billion)
      • 7.5.5.2. Malaysia: ENT Devices Market, by Product, 2019-2032 (USD Billion)
    • 7.5.6. ENT Devices Market - Japan
      • 7.5.6.1. Japan: ENT Devices Market, by End User, 2019-2032 (USD Billion)
      • 7.5.6.2. Japan: ENT Devices Market, by Product, 2019-2032 (USD Billion)
    • 7.5.7. ENT Devices Market - Indonesia
      • 7.5.7.1. Indonesia: ENT Devices Market, by End User, 2019-2032 (USD Billion)
      • 7.5.7.2. Indonesia: ENT Devices Market, by Product, 2019-2032 (USD Billion)
    • 7.5.8. ENT Devices Market - South Korea
      • 7.5.8.1. South Korea: ENT Devices Market, by End User, 2019-2032 (USD Billion)
      • 7.5.8.2. South Korea: ENT Devices Market, by Product, 2019-2032 (USD Billion)
  • 7.6. ENT Devices Market - Middle East & Africa
    • 7.6.1. Middle East & Africa: ENT Devices Market, by End User, 2019-2032 (USD Billion)
    • 7.6.2. Middle East & Africa: ENT Devices Market, by Product, 2019-2032 (USD Billion)
    • 7.6.3. ENT Devices Market - Saudi Arabia
      • 7.6.3.1. Saudi Arabia: ENT Devices Market, by End User, 2019-2032 (USD Billion)
      • 7.6.3.2. Saudi Arabia: ENT Devices Market, by Product, 2019-2032 (USD Billion)
    • 7.6.4. ENT Devices Market - UAE
      • 7.6.4.1. UAE: ENT Devices Market, by End User, 2019-2032 (USD Billion)
      • 7.6.4.2. UAE: ENT Devices Market, by Product, 2019-2032 (USD Billion)
    • 7.6.5. ENT Devices Market - Israel
      • 7.6.5.1. Israel: ENT Devices Market, by End User, 2019-2032 (USD Billion)
      • 7.6.5.2. Israel: ENT Devices Market, by Product, 2019-2032 (USD Billion)
    • 7.6.6. ENT Devices Market - South Africa
      • 7.6.6.1. South Africa: ENT Devices Market, by End User, 2019-2032 (USD Billion)
      • 7.6.6.2. South Africa: ENT Devices Market, by Product, 2019-2032 (USD Billion)
  • 7.7. ENT Devices Market - Latin America
    • 7.7.1. Latin America: ENT Devices Market, by End User, 2019-2032 (USD Billion)
    • 7.7.2. Latin America: ENT Devices Market, by Product, 2019-2032 (USD Billion)
    • 7.7.3. ENT Devices Market - Mexico
      • 7.7.3.1. Mexico: ENT Devices Market, by End User, 2019-2032 (USD Billion)
      • 7.7.3.2. Mexico: ENT Devices Market, by Product, 2019-2032 (USD Billion)
    • 7.7.4. ENT Devices Market - Brazil
      • 7.7.4.1. Brazil: ENT Devices Market, by End User, 2019-2032 (USD Billion)
      • 7.7.4.2. Brazil: ENT Devices Market, by Product, 2019-2032 (USD Billion)
    • 7.7.5. ENT Devices Market - Argentina
      • 7.7.5.1. Argentina: ENT Devices Market, by End User, 2019-2032 (USD Billion)
      • 7.7.5.2. Argentina: ENT Devices Market, by Product, 2019-2032 (USD Billion)

8. Competitive Landscape

  • 8.1. Expansion and Acquisition Analysis
    • 8.1.1. Expansion
    • 8.1.2. Acquisitions
  • 8.2. Partnerships/Collaborations/Agreements/Exhibitions

9. Company Profiles

  • 9.1. Ambu A/S
    • 9.1.1. Company Overview
    • 9.1.2. Financial Performance
    • 9.1.3. Product Benchmarking
    • 9.1.4. Recent Development
  • 9.2. Atos Medical
    • 9.2.1. Company Overview
    • 9.2.2. Financial Performance
    • 9.2.3. Product Benchmarking
    • 9.2.4. Recent Development
  • 9.3. Cochlear Limited
    • 9.3.1. Company Overview
    • 9.3.2. Financial Performance
    • 9.3.3. Product Benchmarking
    • 9.3.4. Recent Development
  • 9.4. Demant A/S
    • 9.4.1. Company Overview
    • 9.4.2. Financial Performance
    • 9.4.3. Product Benchmarking
    • 9.4.4. Recent Development
  • 9.5. GN Store Nord A/S
    • 9.5.1. Company Overview
    • 9.5.2. Financial Performance
    • 9.5.3. Product Benchmarking
    • 9.5.4. Recent Development
  • 9.6. Johnson & Johnson
    • 9.6.1. Company Overview
    • 9.6.2. Financial Performance
    • 9.6.3. Product Benchmarking
    • 9.6.4. Recent Development
  • 9.7. Karl Storz GmbH & Co. KG
    • 9.7.1. Company Overview
    • 9.7.2. Financial Performance
    • 9.7.3. Product Benchmarking
    • 9.7.4. Recent Development
  • 9.8. Medtronic
    • 9.8.1. Company Overview
    • 9.8.2. Financial Performance
    • 9.8.3. Product Benchmarking
    • 9.8.4. Recent Development
  • 9.9. Olympus Corporation
    • 9.9.1. Company Overview
    • 9.9.2. Financial Performance
    • 9.9.3. Product Benchmarking
    • 9.9.4. Recent Development
  • 9.10. Pentax of America, Inc.
    • 9.10.1. Company Overview
    • 9.10.2. Financial Performance
    • 9.10.3. Product Benchmarking
    • 9.10.4. Recent Development
  • 9.11. Rion Co., Ltd.
    • 9.11.1. Company Overview
    • 9.11.2. Financial Performance
    • 9.11.3. Product Benchmarking
    • 9.11.4. Recent Development
  • 9.12. Siemens Healthineers
    • 9.12.1. Company Overview
    • 9.12.2. Financial Performance
    • 9.12.3. Product Benchmarking
    • 9.12.4. Recent Development
  • 9.13. Smith & Nephew
    • 9.13.1. Company Overview
    • 9.13.2. Financial Performance
    • 9.13.3. Product Benchmarking
    • 9.13.4. Recent Development
  • 9.14. Sonova Holding AG
    • 9.14.1. Company Overview
    • 9.14.2. Financial Performance
    • 9.14.3. Product Benchmarking
    • 9.14.4. Recent Development
  • 9.15. Stryker Corporation
    • 9.15.1. Company Overview
    • 9.15.2. Financial Performance
    • 9.15.3. Product Benchmarking
    • 9.15.4. Recent Development
ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦